Topical treatment with a transient receptor potential ankyrin 1 (TRPA1) antagonist reduced nociception and inflammation in a thermal lesion model in rats
| Autor: | Paula Ronsani Ferro, Samira Dal-Toé De Prá, Gabriela de Oliveira Adamante, Romina Nassini, Amanda Spring de Almeida, Paulo Cesar Lock Silveira, Gustavo de Bem Silveira, Cássia Regina Silva, Francesco De Logu, Gabriela Trevisan, Sara Marchesan Oliveira, Caren Tatiane de David Antoniazzi, Mariane Arnoldi Silva, Flávia Karine Rigo, Camila Camponogara |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Male Nociception medicine.drug_class Administration Topical Anti-Inflammatory Agents Pharmaceutical Science Inflammation Pharmacology Anti-inflammatory 03 medical and health sciences 0302 clinical medicine Edema medicine Animals Rats Wistar TRPA1 Cation Channel Analgesics Thermal injury Chemistry food and beverages Disease Models Animal 030104 developmental biology Allodynia Hyperalgesia Purines Burn HC-030031 Hydrogen peroxide NADPH oxidase Acetanilides Burns Nociceptor medicine.symptom 030217 neurology & neurosurgery |
| Zdroj: | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 125 |
| ISSN: | 1879-0720 |
| Popis: | Thermal injury promotes tissue inflammation and pain, which is difficult to control. Different peripheral mechanisms seem to be involved in burn pain, such as free radical-induced damage, but further study is still needed to understand how oxidant substances induced nociceptor sensitization. The transient receptor potential ankyrin 1 (TRPA1) is an ion channel activated by oxidants substances, and it could be sensitized after tissue inflammation. This study evaluated the TRPA1 involvement in nociception and inflammation produced by a thermal injury model. Male Wistar rats were used. The concentration of the TRPA1 antagonist (HC-030031, 0.05%) on base cream was chosen using allyl isothiocyanate intraplantar test. Then, the base cream containing HC-030031 was tested on the thermal injury model (induced by warm water immersion of hind paw, under anesthesia), and silver sulfadiazine (1%) was used as a positive control. Cream treatments on the hind paw were done daily (200 mg/paw) for 6 days after thermal injury. Also, nociception (static and dynamic mechanical allodynia, heat allodynia, and spontaneous pain) or edema were evaluated. On day 6, inflammatory and oxidative parameters were assessed. The base cream containing HC-030031 produced antinociceptive and anti-inflammatory effects (reduced the edema and inflammatory cells infiltration) and decreased the levels of hydrogen peroxide, or superoxide dismutase and NADPH oxidase activities after thermal injury. Thus, this study showed the involvement of the TRPA1 receptor in the nociception and inflammation caused by thermal injury and suggested that TRPA1 antagonists might be useful as novel treatments for pain and inflammation by topical application. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect